Stay updated on ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition to using “Super Intelligence” in place of “Artificial Intelligence.” The site revision label also changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:43:34.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:13:57.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an access-block screen. Users are unable to view trial details, locations, or related information on this page.
    Difference
    20%
    Check dated 2026-09-22T23:06:33.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.6 to v3.7.0, indicating a newer version of the page system. This appears to be a minor update to the page template or backend rather than a modification to study content or details.
    Difference
    0.0%
    Check dated 2026-09-15T21:46:51.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6 on the page. This signals a small maintenance update, with no indicated changes to the study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-09-01T17:55:44.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a small, non-substantive update to the entry. This likely reflects metadata or formatting adjustments rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-11T20:22:00.000Z thumbnail image

Stay in the know with updates to ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.